Lamotrigine for neuropathic pain

References

• Foley KM. Opioids and chronic neuropathic pain. N. Engl J. Med. 348, 1279–1281 (2003).
   PubMed Web of Science ®Google Scholar
• Yarnitsky D, Eisenberg E. Neuropathic pain: between positive and negative ends. Pain Forum 7, 241–242 (1998).
   Web of Science ®Google Scholar
• Sindrup HJ, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83, 389–400 (1999).
   PubMed Web of Science ®Google Scholar
• Peck AW. Clinical pharmacology of lamotrigine. Epilepsia 32(Suppl. 2), S9–S12 (1991).
   PubMedGoogle Scholar
• Garnett WR. Lamotrigine: pharmacokinetics. J. Child Neurol. 12(Suppl. 1), S10–S15 (1997).
   PubMedGoogle Scholar
• Lunardi G, Leandri M, Albano C et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48, 1714–1717 (1997).
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Damunni G, Hoffer E, Baum Y, Krivoy N. Lamotrigine reduces intractable sciatica: correlation between dose, plasma concentration and analgesia. Eur. J. Pain 7, 485–491 (2003).
   PubMed Web of Science ®Google Scholar
• Meyer FP, Banditt P, Schubert A, Schoche J. Lamotrigine concentration in human serum, brain tissue and tumor tissue. Epilepsia 40, 68–73 (1999).
   PubMedGoogle Scholar
• Perruca E. The clinical pharmacology of the new antiepileptic drugs. Pharmacol. Res. 28, 89–106 (1993).
   PubMed Web of Science ®Google Scholar
• Choi H, Morrell MJ. Review of lamotrigine and its clinical applications in epilepsy. Expert Opin. Pharmacotherapy 4, 243–251 (2003).
   PubMed Web of Science ®Google Scholar
• Cunnington M, Tennis P. International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 64, 955–960 (2005).
   PubMed Web of Science ®Google Scholar
• Rubin ET, Lee A, Shinya I. When breastfeeding mothers need CNS-acting drugs. Can. J. Clin. Pharmacol. 11, 257–266 (2004).
   PubMedGoogle Scholar
• Rambeck B, Kurlemann G, Stodieck SRG et al. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur. J. Clin. Pharmacol. 51, 481–484 (1997).
   PubMed Web of Science ®Google Scholar
• Product Information File, Lamictal® (2003).
   Google Scholar
• Lai J, Porreca F, Hunter JC, Gold MS. Voltage-gated sodium channels and hyperalgesia. Ann. Rev. Pharmacol. Toxicol. 44, 371–397 (2004).
   PubMed Web of Science ®Google Scholar
• Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in frequency-dependent potentiation of deep dorsal horn neurons following c-fiber stimulation. Neuropharmacology 26, 1235–1238 (1987).
   PubMed Web of Science ®Google Scholar
• Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II neurochemical studies on the mechanism of action. Epilepsia 27, 490–497 (1986).
   PubMed Web of Science ®Google Scholar
• Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neural voltage-activated sodium channels. Epilepsy Res. 13, 107–112 (1992).
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Alon N, Avraham I, Daud D, Yarnitski D. Lamotrigine in the treatment of diabetic neuropathy. Eur. J. Neurol. 5, 167–173 (1998).
   PubMed Web of Science ®Google Scholar
• McCleane GJ. The symptoms of complex regional pain syndrome Type 1 alleviated with lamotrigine: a report of 8 cases. J. Pain 1, 171–173 (2000).
   Web of Science ®Google Scholar
• Devulder J, DeLaat M. Lamotrigine in the treatment of chronic refractory neuropathic pain. J. Pain Symptom Manage. 19, 398–403 (2000).
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Luria Y, Bracker C, Daud D, Ishai A. Lamotrigine reduces painful neuropathy in patients with diabetes mellitus: a double-blind, randomized, placebo-controlled trial. Neurology 57, 505–509 (2001).
   PubMed Web of Science ®Google Scholar
• Blum D, Biton V, Tuchman M. Lamotrigine does not alter nerve conduction in patients with diabetic neuropathy: results from two double-blind trials. J. Pain 6(3 Suppl. 1), S76 (2005) (Abstract).
   Google Scholar
• Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for HIV-associated neuropathy. Neurology 54, 2115–2119 (2000).
   PubMed Web of Science ®Google Scholar
• Simpson DM, McArthur JC, Olney R et al. Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 60, 1508–1514 (2003).
   PubMed Web of Science ®Google Scholar
• McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind, placebo-controlled trial. Pain 83, 105–107 (1999).
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Sindrup SH, Bach FW, Johannesen IL, Jensen TS. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 96, 375–383 (2002).
   PubMed Web of Science ®Google Scholar
• Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 56, 184–190 (2001).
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain 73, 223–230 (1997).
   PubMed Web of Science ®Google Scholar
• Acharya NV, Pickring RM, Wilton LW, Shakir SAW. The safety and effectiveness of newer antiepileptics: a comparative post-marketing cohort study. J. Clin. Pharmacol. 45, 385–393 (2005).
   PubMed Web of Science ®Google Scholar
• Wadelius M, Karlsson T, Wadelius C et al. Lamotrigine and toxic epidermal necrolysis. Lancet 348, 1041 (1996).
   PubMedGoogle Scholar
• Schaub J, Williamson P, Barnes E, Trewby P. Multisystem adverse reaction to lamotrigine. Lancet 344, 481 (1994).
   PubMed Web of Science ®Google Scholar
• Anderson GD, Miller JW. The newer antiepileptic drugs: their collective role and defining characteristics. Formulary 36, 114–135 (2001).
   Google Scholar
• Schlienger R, Knowles S, Shear N. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 51, 1172–1175 (1998).
   PubMed Web of Science ®Google Scholar
• Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64, 1134–1138 (2005).
   PubMed Web of Science ®Google Scholar
• Lofton AL, Klein-Schwartz W. Evaluation of lamotrigine toxicity reported to poison centers. Ann. Pharmacother. 38, 1811–1815 (2004).
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 43, 365–385 (2002).
   PubMed Web of Science ®Google Scholar
• Faught E, Matsuo FU, Schachter S, Messenheimer J, Womble GP. Long-term tolerability of lamotrigine: data from a 6-year continuation study. Epilepsy Behav. 5, 31–36 (2004).
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP, Ferrie CD, Knott C et al. Interaction of lamotrigine with sodium valproate. Lancet 341, 445 (1993).
   PubMed Web of Science ®Google Scholar
• Yen AWC, Land G, Wearherley BC et al. Sodium valproate acutely inhibits lamotrigine metabolism. Br. J. Clin. Pharmacol. 33, 511–513 (1992).
   PubMed Web of Science ®Google Scholar
• Richens A. Safety of lamotrigine. Epilepsia 36(Suppl. 2), 37–40, 99 (1995).
   PubMed Web of Science ®Google Scholar
• Prescribing Information for Lamictal®.
   Google Scholar
• Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med. 352, 1324–1334 (2005).
   PubMed Web of Science ®Google Scholar